223 related articles for article (PubMed ID: 29621586)
1. Long non-coding RNA DILC suppresses cell proliferation and metastasis in colorectal cancer.
Gu LQ; Xing XL; Cai H; Si AF; Hu XR; Ma QY; Zheng ML; Wang RY; Li HY; Zhang XP
Gene; 2018 Aug; 666():18-26. PubMed ID: 29621586
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA DILC suppresses bladder cancer cells progression.
Ma QY; Li SY; Li XZ; Zhou TF; Zhao YF; Liu FL; Yu XN; Lin J; Chen FY; Cao J; Xi HJ; Li HY
Gene; 2019 Aug; 710():193-201. PubMed ID: 31176734
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.
Liang C; Yang P; Han T; Wang RY; Xing XL; Si AF; Ma QY; Chen Z; Li HY; Zhang B
Gene; 2019 Apr; 694():102-110. PubMed ID: 30716440
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer.
Li QG; Xu XQ; Zhou DY; Jia ZB; Yu BF; Xu FG; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3320-3325. PubMed ID: 31081085
[TBL] [Abstract][Full Text] [Related]
6. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression.
Zhang H; Wei P; Lv W; Han X; Yang J; Qin S
Cell Biosci; 2019; 9():81. PubMed ID: 31592114
[TBL] [Abstract][Full Text] [Related]
8. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.
Wang J; Zhou J; Jiang C; Zheng J; Namba H; Chi P; Asakawa T
Mol Oncol; 2019 Nov; 13(11):2344-2360. PubMed ID: 31246342
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1.
Zhang C; Wang L; Jin C; Zhou J; Peng C; Wang Y; Xu Z; Zhang D; Huang Y; Zhang Y; Ji D; Peng W; Jin K; Tang J; Feng Y; Sun Y
Cell Death Dis; 2021 Feb; 12(2):224. PubMed ID: 33637680
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2.
Han Q; Xu L; Lin W; Yao X; Jiang M; Zhou R; Sun X; Zhao L
Oncogene; 2019 Apr; 38(16):3019-3032. PubMed ID: 30575817
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA DILC is involved in sepsis by modulating the signaling pathway of the interleukin‑6/signal transducer and activator of transcription 3/Toll‑like receptor 4 axis.
Huang W; Huang L; Wen M; Fang M; Deng Y; Zeng H
Mol Med Rep; 2018 Dec; 18(6):5775-5783. PubMed ID: 30365067
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lncRNA DILC attenuates neuropathic pain via the SOCS3/JAK2/STAT3 pathway.
Liu Y; Feng L; Ren S; Zhang Y; Xue J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510145
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment.
Wu K; Zhao Z; Liu K; Zhang J; Li G; Wang L
Cell Cycle; 2017 Jul; 16(13):1295-1301. PubMed ID: 28632999
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
[TBL] [Abstract][Full Text] [Related]
15. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling.
Fu Q; Jiang Y; Zhang D; Liu X; Guo J; Zhao J
Mol Cell Biochem; 2016 Jul; 418(1-2):189-98. PubMed ID: 27344168
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long non-coding RNA SBDSP1 suppresses tumor growth and invasion in colorectal cancer.
Shi D; Liang L; Zheng H; Cai G; Li X; Xu Y; Cai S
Biomed Pharmacother; 2017 Jan; 85():355-361. PubMed ID: 27890432
[TBL] [Abstract][Full Text] [Related]
18. Downregulating long non-coding RNA CCAT5 inhibits tumor growth, invasion and metastasis in colorectal cancer through suppressing STAT3.
Wang Y; Yan XL; Tian SK
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7899-7904. PubMed ID: 31599415
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
Han X; Wang L; Ning Y; Li S; Wang Z
Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
